|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 17, 2017 ) Continuous glucose monitoring (CGM) is the novel technology to measure blood glucose in real-time throughout the day and night. Glucose sensors are placed under the skin in order to measure glucose levels in blood. The transmitters are sending radiofrequency signals to a monitoring and display device. Adoption of advanced technologies to monitor the glucose levels able to create demand for continuous glucose monitoring devices market.
Continuous glucose monitoring devices market is expected to gain traction due to increased global prevalence of diabetes coupled with adoption of technological advancements. According to WHO, approximately 108 million adults were living with diabetes in 1980; it is reached to 422 million by 2014. The prevalence is doubled in adult population. Favourable reimbursement policies for continuous glucose monitoring devices expected to boost the market over the forecast period.
Lack funding and dearth of advanced healthcare infrastructure in lower-income countries is hamper the market. Most of primary health-care practitioners unable to access basic technologies to manage diabetes.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-continuous-glucose-monitoring-devices-market/#ulp-4H8Z4LpNMLEuOnnx
Continuous glucose monitoring devices market has been segmented based on product, and end user.
Based on the product, continuous glucose monitoring devices market has been segmented as follows
• Glucose sensors
• Transmitters and monitoring devices
• Insulin Pumps
Based on end user, continuous glucose monitoring devices market has been segmented as follows
• Hospitals
• Diagnostic canters
• Clinics
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-continuous-glucose-monitoring-devices-market/#ulp-c654SbFYO64MsOhu
Diabetes imposes huge economic burden on global healthcare system. Direct medical cost associated with diabetes for diagnosis and treatment is increasing gradually. The International Diabetes Federation (IDF) estimates states that, global diabetes care spending has tripled between 2003 to 2013. Favourable government policies in most countries to control diabetes create awareness to reduce risk factors and improve management of diabetes able to create demand for monitoring devices. Rising awareness levels and increased adoption of state-of-art technologies in emerging economies expected to boost the continuous glucose monitoring devices market over the forecast period.
Continuous glucose monitoring devices market has been segmented in to following regions North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.
U.S. is expected to account for predominate market share in North America, owing to wide range of diabetes population in the country. Rise in the diabetes prevalence and inclined towards novel diagnostic devices is expected to drive market over the forecast period.
Mexico continuous glucose monitoring devices market is expected to accelerate due to increased prevalence of obesity and overweight. For instance, prevalence of obesity is more than 33% in children and 70% in adults. The obesity is the prime factor, leads to diabetes. Mexico has the highest prevalence of diabetes among OECD countries.
Asia Pacific continuous glucose monitoring devices market is expected to expand at unprecedented CAGR due to increase in the diabetes prevalence in India and China. The rise in the healthcare expenditure in emerging economies is expected to boost the market growth during the forecast period.
The prevalence of diabetes is high in low and middle income countries than the higher income countries. It is steadily increasing form the past three decades. According to IDF statistics, Saudi Arabia diabetes prevalence is 23.9% in 2014.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-continuous-glucose-monitoring-devices-market/#ulp-14mlyhjMGhVjZqa3
Some of market players in the Continuous glucose monitoring (CGM) devices market include Medtronic, Dexcom, Abbott Laboratories Inc., Roche Diagnostics, and Animas Corporation, Nemaura Medical, Glucowise, International Biomedical, Tandem Diabetes care, and Optiscan. Robust R&D investments enable offer innovative products to monitor blood glucose levels. Companies are entering into strategic partnerships to expand geographical footprints.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Precision Business Insights
Sales
+1-866-598-1553
sales@precisionbusinessinsights.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
